The key facts
- Nicole Kidman will receive an honorary César at the 52nd ceremony on February 25, 2027, at the Olympia in Paris
- The award was announced by the French film academy together with the Canal+ channel
- Kidman is the holder of an Oscar (2003, The Hours), the Volpi Cup (2024, Babygirl), and an Emmy for Big Little Lies
Honorary César for Nicole Kidman
The French film academy Académie des Arts et Techniques du Cinéma, which presents the César — the French equivalent of the Oscar — has announced that Nicole Kidman will receive an honorary award. The announcement was made jointly with the Canal+ channel. In its statement, the academy said the award honors an actress and producer who has 'never let fame dictate her choice of work.' The presentation will take place at the 52nd César ceremony on February 25, 2027, at the Olympia venue in Paris.
Career and Previous Awards
Kidman gained worldwide fame in 1989 thanks to her role in the film Dead Calm, after which she starred in Days Of Thunder, Practical Magic, Eyes Wide Shut, Moulin Rouge!, The Others, and Dogville. In 2003, she won the Oscar for Best Actress for her portrayal of Virginia Woolf in The Hours, and in 2024 she received the Volpi Cup of the Venice Film Festival for the film Babygirl. As a producer, she co-founded the company Blossom Films, behind the series Big Little Lies, The Undoing, and Nine Perfect Strangers, in which she also played the leading roles; for Big Little Lies she won an Emmy as Outstanding Lead Actress in a Limited Series or TV Movie. Among her other distinctions are the title of Companion of the Order of Australia (2006), the anniversary award of the 70th Cannes Film Festival (2017), and the American Film Institute award for her contribution to cinema (2024), which made her the first Australian woman to receive this honor. Off screen, Kidman has been a UNICEF Goodwill Ambassador since 1994 and a Goodwill Ambassador for UN Women since 2006; she has helped raise several million dollars for programs fighting women's cancers, including at Stanford and the Vanderbilt-Ingram Cancer Center.
